Início › Câncer Endometrial › Distrito de Columbia › Washington
Ensaios clínicos de Câncer Endometrial em Washington, DC
18 estudos para Câncer Endometrial estão buscando participantes em locais em Washington e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecrutandoFase 3
- MedStar Washington Hospital Center, Washington D.C.
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- Walter Reed National Military Medical Center, Bethesda · a 7 mi de distância
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RecrutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecrutandoFase 1
- Georgetown University Medical Center, Washington D.C.
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
RecrutandoFase 3
- MedStar Washington Hospital Center, Washington D.C.
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RecrutandoFase 3
- MedStar Washington Hospital Center ( Site 5005), Washington D.C.
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RecrutandoFase 3
- MedStar Washington Hospital, Washington D.C.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RecrutandoFase 3
- Research Site, Silver Spring · a 7 mi de distância
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RecrutandoFase 1
- Georgetown University Medical Center, Washington D.C.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecrutandoFase 1/2
- Children's National Medical Center, Washington D.C.
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RecrutandoFase 1
- Normunity Investigational Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- National Institutes of Health, Bethesda · a 7 mi de distância
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecrutandoFase 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · a 7 mi de distância
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
RecrutandoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Silver Spring · a 7 mi de distância
- Massive Bio SYNERGY-AI site, Bethesda · a 7 mi de distância
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
RecrutandoFase 1
- Holy Cross Hospital, Silver Spring · a 7 mi de distância
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
RecrutandoFase 2/3
- Maryland Oncology Hematology, P.A., Silver Spring · a 7 mi de distância
Ensaios de Câncer Endometrial em outras cidades
- Houston, TX68 estudos
- New York City, NY52 estudos
- Boston, MA50 estudos
- Arlington, VA39 estudos
- Nashville, TN38 estudos
- Los Angeles, CA34 estudos
- St. Louis, MO29 estudos
- Philadelphia, PA28 estudos
- San Antonio, TX27 estudos
- Columbus, OH25 estudos
- Chicago, IL25 estudos
- Oklahoma City, OK25 estudos
Outros estudos em Washington
- Câncer (todos os tipos)58 estudos
- Câncer de Pulmão de Não Pequenas Células55 estudos
- Câncer de Mama46 estudos
- Câncer Metastático43 estudos
- Câncer de Pulmão41 estudos
- Câncer de Próstata38 estudos
- Obesidade33 estudos
- Câncer Colorretal29 estudos
- Doença Cardiovascular28 estudos
- Câncer de Bexiga26 estudos
- Leucemia Mieloide Aguda24 estudos
- Câncer de Ovário23 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.